Clinical Trials in the USA / NCT07420907
Recruiting
Observational
Study of the Progression of Chronic Cardiovascular Conditions
NCT07420907 · tracked via the Priya Life Science USA tracker
Condition(s) studied
Cardiovascular Disease (CVD)Heart FailureAortic StenosisAortic Stenosis DiseaseHypertensionHypertension (HTN)Hypertrophic Cardiomyopathy PatientsHypertrophic Cardiomyopathy Without ObstructionHypertrophic Cardiomyopathy, ObstructiveDilated Cardiomyopathy (DCM)Dilated CardiomyopathyDilated Cardiomyopathy, Familial
Study summary
This study will collect physiologic data in patients with cardiovascular conditions and observe the natural history of those conditions for research purposes.
Eligibility
Inclusion Criteria:
* 18 years of age and older
* Ability to understand study assessments and give informed consent to data collection
* Ability to comply with the study protocol
* Ability to understand and respond to instructions in English
* Has diagnosis of qualifying Cardiovascular Disease(s), including but not limited to: HF, AS, HCM, HTN, DCM, etc. Additional CVD may be included at discretion of the investigators.
* Resides in the United States
Exclusion Criteria:
* Allergy to adhesive used in biosensor patch
* Life-threatening disease process outside of area under study, such as actively treated cancer or being actively considered for organ pre-transplant (such as hepatic failure; end-stage renal disease).
* Severe CVD defined by hospital admission for cardiac diagnosis within 30 days of enrollment or documentation of NYHA functional class IV
* \-- For participants who do not qualify due to this exclusion, and have not been hospitalized within 30 days of enrollment, they may reapply to enroll in the study
* Self-reported weight of 400 pounds or greater
Primary outcome measure(s)
- Longitudinal Assessment of Clinical Status — Baseline through each 90-day cycle
Measured by Heart Rate (beats per minute) - Longitudinal Assessment of Clinical Status — Baseline through each 90-day cycle
Heart Rate Variability (per millisecond) - Longitudinal Assessment of Clinical Status — Baseline through each 90-day cycle
percentage of Atrial Fibrillation Burden (duration of time per day of demonstrated AF) - Longitudinal Assessment of Clinical Status — Baseline through each 90-day cycle
Breaths per minute
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Prolaio | Chicago | Illinois | Recruiting |
More Prolaio trials in the USA
Other trials for the same condition
Official registry record
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07420907 on ClinicalTrials.gov ↗ ← All trials in the USA